TABLE 1.

Biodistribution Data of 89Zr-7E11 Administered Intravenously to Mice Bearing Subcutaneous LNCaP Tumors

Organ24 h (n = 5)48 h (n = 5)96 h (n = 5)120 h (n = 5)Block (300 μg of mAb) at 48 h (n = 5)
Blood32.63 ± 4.8923.82 ± 4.3412.37 ± 1.886.60 ± 2.9417.21 ± 0.83
Heart7.33 ± 1.104.65 ± 1.633.04 ± 0.612.95 ± 0.783.90 ± 0.58
Lungs12.84 ± 2.607.55 ± 2.437.98 ± 1.467.79 ± 2.766.61 ± 0.68
Liver53.75 ± 3.8342.74 ± 3.1336.08 ± 2.5732.98 ± 0.6534.14 ± 1.64
Spleen28.64 ± 4.4429.90 ± 4.1226.48 ± 2.1031.26 ± 4.0421.36 ± 2.69
Kidney27.43 ± 5.1321.61 ± 2.2715.84 ± 3.3215.20 ± 3.3814.82 ± 2.09
Intestine3.39 ± 0.664.91 ± 2.198.18 ± 4.611.99 ± 0.294.56 ± 2.08
Muscle1.88 ± 0.511.02 ± 0.531.20 ± 0.760.75 ± 0.181.24 ± 0.39
Bone4.10 ± 0.916.25 ± 1.324.52 ± 0.864.93 ± 1.054.98 ± 2.19
LNCaP
 Irradiated24.70 ± 7.2440.61 ± 7.5151.79 ± 7.4352.71 ± 11.138.84 ± 0.89
 Control20.35 ± 7.5022.82 ± 3.5836.94 ± 6.2725.23 ± 4.825.93 ± 2.11
 Irradiated to blood0.76 ± 0.331.8 ± 0.514.32 ± 1.219.86 ± 5.590.51 ± 0.04
 Control to blood0.62 ± 0.220.96 ± 0.213.02 ± 0.585.21 ± 2.770.40 ± 0.03
  • Data are expressed as %ID/g ± SD.